UY35789A - INTRAVAGINAL USE OF THE 18-METIL-15ß, 16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, INTRAVAGIN ALES RINGS THAT INCLUDE 18-METHYL-15ß, 16ß-METILEN-19-NOR-20 -ESPIROX-4-EN-3-ONAS AND ITS USE IN THE ANTICONCE PCIÓN - Google Patents

INTRAVAGINAL USE OF THE 18-METIL-15ß, 16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, INTRAVAGIN ALES RINGS THAT INCLUDE 18-METHYL-15ß, 16ß-METILEN-19-NOR-20 -ESPIROX-4-EN-3-ONAS AND ITS USE IN THE ANTICONCE PCIÓN

Info

Publication number
UY35789A
UY35789A UY0001035789A UY35789A UY35789A UY 35789 A UY35789 A UY 35789A UY 0001035789 A UY0001035789 A UY 0001035789A UY 35789 A UY35789 A UY 35789A UY 35789 A UY35789 A UY 35789A
Authority
UY
Uruguay
Prior art keywords
espirox
metilen
onas
methyl
pción
Prior art date
Application number
UY0001035789A
Other languages
Spanish (es)
Inventor
Dr Bernhard Lindenthal
Dr Hans-Peter Muhn
Dr Birte Maria Hofmann
Dr Lüder M Fels
Dr Reinahrd Nubbemeyer
Pihlaja Jyrki
Dr Svante Holmberg
Fuhrmann Ulrike
Dr Norbert Schmees
Jukarainen Harri
Dr Lars Röse
Valo Tuula
Dr Katja Prelle
Original Assignee
Bayer Oy
Bayer Pharma AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Oy, Bayer Pharma AG filed Critical Bayer Oy
Publication of UY35789A publication Critical patent/UY35789A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gynecology & Obstetrics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nanotechnology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)

Abstract

Uso intravaginal de las 18-metil-15ß,16ß-metilen-19-nor-20-espirox-4-en-3-onas de la fórmula general (I). Anillo intravaginal que comprende 18-metil-15ß,16ß-metilen-19-nor-20-espirox-4-en-3-onas de la fórmula general I. Su uso en la anticoncepción.Intravaginal use of the 18-methyl-15ß, 16ß-methylene-19-nor-20-espirox-4-en-3-ones of the general formula (I). Intravaginal ring comprising 18-methyl-15ß, 16ß-methylene-19-nor-20-espirox-4-en-3-ones of the general formula I. Its use in contraception.

UY0001035789A 2013-10-17 2014-10-17 INTRAVAGINAL USE OF THE 18-METIL-15ß, 16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, INTRAVAGIN ALES RINGS THAT INCLUDE 18-METHYL-15ß, 16ß-METILEN-19-NOR-20 -ESPIROX-4-EN-3-ONAS AND ITS USE IN THE ANTICONCE PCIÓN UY35789A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361892398P 2013-10-17 2013-10-17

Publications (1)

Publication Number Publication Date
UY35789A true UY35789A (en) 2015-05-29

Family

ID=51842499

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001035789A UY35789A (en) 2013-10-17 2014-10-17 INTRAVAGINAL USE OF THE 18-METIL-15ß, 16ß-METILEN-19-NOR-20-ESPIROX-4-EN-3-ONAS, INTRAVAGIN ALES RINGS THAT INCLUDE 18-METHYL-15ß, 16ß-METILEN-19-NOR-20 -ESPIROX-4-EN-3-ONAS AND ITS USE IN THE ANTICONCE PCIÓN

Country Status (4)

Country Link
AR (1) AR098059A1 (en)
TW (1) TW201605457A (en)
UY (1) UY35789A (en)
WO (1) WO2015055789A1 (en)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US3920805A (en) 1971-12-09 1975-11-18 Upjohn Co Pharmaceutical devices and method
US4215691A (en) 1978-10-11 1980-08-05 Alza Corporation Vaginal contraceptive system made from block copolymer
US4292965A (en) 1978-12-29 1981-10-06 The Population Council, Inc. Intravaginal ring
DE3040978A1 (en) 1980-10-28 1982-05-27 Schering Ag, 1000 Berlin Und 4619 Bergkamen VAGINAL RING
FR2618329B1 (en) 1987-07-22 1997-03-28 Dow Corning Sa METHOD OF MANUFACTURING A RING CAPABLE OF ENSURING THE RELEASE OF A THERAPEUTIC AGENT, AND RING MANUFACTURED BY THIS METHOD
FI90627C (en) 1992-07-31 1994-03-10 Leiras Oy Apparatus for providing a medicine rod with a jacket
PH30867A (en) 1992-07-31 1997-12-09 Leiras Oy Method and equipment for installing a medicine capsule on a support.
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
DE102006030416A1 (en) 2006-06-29 2008-01-03 Bayer Schering Pharma Ag 18-methyl-19-nor-androst-4-ene-17,17-spiroethers (18-methyl-19-nor-20-spirox-4-en-3-ones) and pharmaceutical compositions containing them
DE102008026793A1 (en) * 2008-06-02 2009-12-03 Bayer Schering Pharma Aktiengesellschaft C-ring-substituted pregn-4-ene-21,17-carbolactones, as well as pharmaceutical compositions containing them
FI121000B (en) 2008-11-19 2010-06-15 Bayer Schering Pharma Oy Intravaginal delivery system and method for its preparation
TW201350122A (en) * 2012-04-23 2013-12-16 Bayer Pharma AG Intrauterine use of 18-methyl-15 β , 16 β -methylene-19-nor-20-spirox-4-en-3-ones, intrauterine systems comprising 18-methyl-15 β , 16 β -methylene-19-nor-20-spirox-4-en-3-ones, and use thereof in contraception and gynaecological treatmen

Also Published As

Publication number Publication date
WO2015055789A1 (en) 2015-04-23
TW201605457A (en) 2016-02-16
AR098059A1 (en) 2016-04-27

Similar Documents

Publication Publication Date Title
DOP2017000078A (en) INDAZOLS REPLACED WITH BENCILO AS INHIBITORS OF BUB1.
CL2017002422A1 (en) Maitansinoid derivatives, conjugates thereof, and methods of use.
TWD188190S (en) Ring
TWD179814S (en) Ring
TWD185952S (en) Grille
TWD178827S (en) Ring
TWD175463S (en) Ring
TWD176801S (en) Ring
TWD185066S (en) Wireless access point device
TWD172709S (en) Air purifier
TWD175456S (en) Ring
TWD180147S (en) Water purifier
DOP2015000219A (en) HETEROARILO COMPOUNDS AND ITS USES
TWD169283S (en) Air purifier
UY34566A (en) 1,4? DIHYDROPIRIMIDINES 4.4? DISUSTITUTED AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
TWD169282S (en) Air purifier
TWD169280S (en) Air purifier
EA201691194A1 (en) RHC STIMULATORS
UY34632A (en) OXAZOLIDIN- 2- ONA COMPOUNDS AND USES OF THE SAME
TWD169281S (en) Air purifier
UY34797A (en) BICYCLICALLY REPLACED URACILES AND USE OF THE SAME
UY34200A (en) 3- (FLUOROVINIL) PIRAZOLES AND ITS USE
TWD182433S (en) Pruners
UY34590A (en) PHENYLIMIDAZOPIRAZOLES REPLACED AND ITS USE
TWD187227S (en) Water purifier

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20211215